Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Danorrnon Aug 11, 2019 8:28pm

238 Views

Post# 30016604

RE:Be Careful

Probably related to the short prospectus showing shares at .30 with a half purchase warrant at .40.

88guy88 wrote: it it such a slam dunk why has the price fallen back from 40 cents to 33 ish....it ran up on comments from McWhirter on BNN and then profit taking by traders and the price decline also is very telling that the risk is very high with Biotech companies......the price can go south in a big hurry with a not so snappy Phase result....this week will likely head back to pre McWhirter comments level.....under 30 cents likely but will have to see how things play out....big risk big reward.....oh yeah and big risk big losses.....rememeber its not monopoly money!

Bullboard Posts

Gold vs. bitcoin, where should you invest?